Defunct Company
Total Trials
15
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,964
NCT01748838
Phase 1 Study Assessing the Safety and Tolerability of CTX-4430
Phase: Phase 1
Role: Collaborator
Start: Dec 31, 2012
Completion: Sep 30, 2013
NCT02389348
A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265
Phase: Phase 1/2
Start: Feb 28, 2015
Completion: Jun 30, 2015
NCT02385760
CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris
Phase: Phase 2
Start: Apr 30, 2015
Completion: Aug 31, 2016
NCT02431637
Experimental Falciparum Transmission to Anopheles
Completion: Sep 30, 2016
NCT02431650
Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent
NCT02573857
A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection
Start: Oct 31, 2015
Completion: May 31, 2016
NCT02783820
Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A
Start: May 31, 2016
Completion: Dec 31, 2016
NCT02783833
MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B
Completion: Jan 16, 2017
NCT02867059
SJ733 Induced Blood Stage Malaria Challenge Study
Start: Sep 13, 2016
Completion: Dec 22, 2016
NCT03542149
Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP
Start: Apr 23, 2018
Completion: Apr 19, 2019
NCT03792308
A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR206 in Healthy Volunteers
Start: Dec 18, 2018
Completion: Dec 23, 2019
NCT03748836
Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety
Start: Jan 29, 2019
Completion: Nov 18, 2019
NCT03880474
Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
Start: Mar 18, 2019
Completion: Jan 21, 2020
NCT04092725
Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects
Start: Sep 9, 2019
Completion: Jan 3, 2020
NCT04092751
Study to Evaluate the Effect of SCY-078 (Ibrexafungerp) on the PK of Pravastatin in Healthy Subjects
Start: Nov 22, 2019
Completion: Dec 20, 2019